{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:40:50Z","timestamp":1780382450786,"version":"3.54.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-022-03414-y","type":"journal-article","created":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T05:13:38Z","timestamp":1669180418000},"page":"301-308","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The use of natural killer cell activity and PPD test in the prediction of results in intravesical BCG treatment of patients with nonmuscle-invasive bladder cancer"],"prefix":"10.1007","volume":"55","author":[{"given":"Gokhan","family":"Yazici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersin","family":"Gokmen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-0178","authenticated-orcid":false,"given":"Mustafa Gokhan","family":"Kose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bugra","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burak","family":"Arslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ozalevli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Gov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enver","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"3414_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.eururo.2012.08.061","volume":"63","author":"M Burger","year":"2013","unstructured":"Burger M, Oosterlinck W, Konety B et al (2013) ICUD-EAU International Consultation on Bladder Cancer 2012: non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol 63:36\u201344. https:\/\/doi.org\/10.1016\/j.eururo.2012.08.061","journal-title":"Eur Urol"},{"key":"3414_CR2","first-page":"681","volume":"74","author":"C Fragkoulis","year":"2021","unstructured":"Fragkoulis C, Glykas I, Bamias A, Stathouros G, Papadopoulos G, Ntoumas K (2021) Novel treatments in BCG failure. Where do we stand today? Arch Esp Urol 74:681\u2013691","journal-title":"Arch Esp Urol"},{"key":"3414_CR3","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/apm.13011","volume":"128","author":"ES Larsen","year":"2020","unstructured":"Larsen ES, Joensen UN, Poulsen AM, Goletti D, Johansen IS (2020) Bacillus Calmette-Guerin immunotherapy for bladder cancer: a review of immunological aspects, clinical effects and BCG infections. APMIS 128:92\u2013103. https:\/\/doi.org\/10.1111\/apm.13011","journal-title":"APMIS"},{"key":"3414_CR4","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/j.juro.2009.07.016","volume":"182","author":"J Fernandez-Gomez","year":"2009","unstructured":"Fernandez-Gomez J, Madero R, Solsona E et al (2009) Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model. J Urol 182:2195\u20132203. https:\/\/doi.org\/10.1016\/j.juro.2009.07.016","journal-title":"J Urol"},{"issue":"5","key":"3414_CR5","doi-asserted-by":"publisher","first-page":"CD006885","DOI":"10.1002\/14651858.CD006885.pub2","volume":"11","author":"PF Shang","year":"2011","unstructured":"Shang PF, Kwong J, Wang ZP et al (2011) Intravesical Bacillus Calmette-Guerin versus epirubicin for Ta and T1 bladder cancer. Cochrane Database Syst Rev 11(5):CD006885. https:\/\/doi.org\/10.1002\/14651858.CD006885.pub2 (PMID: 21563157)","journal-title":"Cochrane Database Syst Rev"},{"key":"3414_CR6","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2017.1293212","volume":"6","author":"EM Garcia-Cuesta","year":"2017","unstructured":"Garcia-Cuesta EM, Esteso G, Ashiru O et al (2017) Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes. Oncoimmunology 6:e1293212. https:\/\/doi.org\/10.1080\/2162402X.2017.1293212 (PMID: 28507799; PMCID: PMC5414876)","journal-title":"Oncoimmunology"},{"key":"3414_CR7","doi-asserted-by":"publisher","first-page":"233","DOI":"10.5301\/uro.5000063","volume":"81","author":"K Krpina","year":"2014","unstructured":"Krpina K, Babarovic E, Dordevic G, Markic A, Jonjic N (2014) Impact of NK cell count on bladder cancer recurrence. Urologia 81:233\u2013236. https:\/\/doi.org\/10.5301\/uro.5000063","journal-title":"Urologia"},{"key":"3414_CR8","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1159\/000325265","volume":"3","author":"YT Bryceson","year":"2011","unstructured":"Bryceson YT, Chiang SC, Darmanin S et al (2011) Molecular mechanisms of natural killer cell activation. J Innate Immun 3:216\u2013226. https:\/\/doi.org\/10.1159\/000325265","journal-title":"J Innate Immun"},{"key":"3414_CR9","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","volume":"356","author":"K Imai","year":"2000","unstructured":"Imai K, Matsuyama S, Miyake S, Suga K, Nakachi K (2000) Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population. Lancet 356:1795\u20131799. https:\/\/doi.org\/10.1016\/S0140-6736(00)03231-1","journal-title":"Lancet"},{"key":"3414_CR10","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/bjc.1979.147","volume":"40","author":"P Hersey","year":"1979","unstructured":"Hersey P, Edwards A, Honeyman M, McCarthy WH (1979) Low natural-killer-cell activity in familial melanoma patients and their relatives. Br J Cancer 40:113\u2013122. https:\/\/doi.org\/10.1038\/bjc.1979.147","journal-title":"Br J Cancer"},{"key":"3414_CR11","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/ijc.2910340303","volume":"34","author":"HF Pross","year":"1984","unstructured":"Pross HF, Sterns E, MacGillis DR (1984) Natural killer cell activity in women at \u201chigh risk\u201d for breast cancer, with and without benign breast syndrome. Int J Cancer 34:303\u2013308. https:\/\/doi.org\/10.1002\/ijc.2910340303","journal-title":"Int J Cancer"},{"key":"3414_CR12","first-page":"869","volume":"77","author":"SP Schantz","year":"1986","unstructured":"Schantz SP, Shillitoe EJ, Brown B, Campbell B (1986) Natural killer cell activity and head and neck cancer: a clinical assessment. J Natl Cancer Inst 77:869\u2013875","journal-title":"J Natl Cancer Inst"},{"key":"3414_CR13","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/ijc.25521","volume":"128","author":"C Haggstrom","year":"2011","unstructured":"Haggstrom C, Stocks T, Rapp K et al (2011) Metabolic syndrome and risk of bladder cancer:prospective cohort study in the metabolic syndrome and cancer project (Me-Can). Int J Cancer 128:1890\u20131398. https:\/\/doi.org\/10.1002\/ijc.25521","journal-title":"Int J Cancer"},{"key":"3414_CR14","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1002\/ijc.27878","volume":"132","author":"CC Newton","year":"2013","unstructured":"Newton CC, Gapstur SM, Campbell PT, Jacobs EJ (2013) Type 2 diabetes mellitus, insulin-use and risk of bladder cancer in a large cohort study. Int J Cancer 132:2186\u20132191. https:\/\/doi.org\/10.1002\/ijc.27878","journal-title":"Int J Cancer"},{"key":"3414_CR15","first-page":"458","volume":"16","author":"W Krajewski","year":"2019","unstructured":"Krajewski W, Zdrojowy R, Grzegolka J et al (2019) Does mantoux test result predicts BCGimmunotherapy efficiency and severe toxicity in non-muscle invasive bladder cancer. Urol J 16:458\u2013462","journal-title":"Urol J"},{"key":"3414_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/s0022-5347(17)39854-3","volume":"143","author":"J Carballido","year":"1990","unstructured":"Carballido J, Alvarez-Mon M, Solovera OJ, Menendez-Ondina L, Durantez A (1990) Clinicalsignificance of natural killer activity in patients with transitional cell carcinoma of the bladder. J Urol 143:29\u201333. https:\/\/doi.org\/10.1016\/s0022-5347(17)39854-3","journal-title":"J Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-022-03414-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-022-03414-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-022-03414-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T02:48:58Z","timestamp":1674269338000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-022-03414-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":16,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["3414"],"URL":"https:\/\/doi.org\/10.1007\/s11255-022-03414-y","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"assertion":[{"value":"11 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest or non-financial interest in the subject matter or materials discussed in this manuscript. There is no conflicting interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Approval was obtained from the ethics committee of Gaziosmanpasa Training and Research Hospital. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}